Skip to main content
. Author manuscript; available in PMC: 2016 May 25.
Published in final edited form as: NeuroRehabilitation. 2012;31(4):367–372. doi: 10.3233/NRE-2012-00805

Table 1.

Selected pharmacologic treatments for conditions in which central sensitization has been demonstrated

Condition Pharmacologic treatments References
Fibromyalgia Duloxetine* , milnacipran* ,
pregabalin* , amitryptiline,
paroxetine, citalopram
[8]
Irritable bowel syndrome Imipramine, amitryptiline,
gabapentin, pregabalin
[21,54]
Chronic fatigue syndrome Amitryptiline, doxepin,
citalopram, escitalopram
[53]
Chronic headache Amitryptyline, nortriptyline,
divalproex, propranolol,
gabapentin, topirimate
[22]
Complex regional pain
syndrome
Amytal, ketamine [44]
*

Food and Drug Administration approved.